文献速递产科

产前抑郁症状与产后显著阿片类药物使用相关

Antepartum depressive symptoms are associated with significant postpartum opioid use.
PubMed 文献 · Am J Obstet Gynecol MFM · 2023-05-06

这项2017至2019年城市学术医疗中心的回顾性队列研究纳入6094例分娩,评估产前抑郁症状(爱丁堡产后抑郁量表≥10)与产后住院期间显著阿片类药物使用的关联。产前抑郁症状者产后显著阿片使用风险升高(调整风险比1.5,95%CI 1.1-2.0),剖宫产后更明显(调整风险比1.8,95%CI 1.1-2.7),阴道分娩后不再显著。

要点

  • 产前抑郁症状与产后显著阿片类药物使用风险升高相关,调整风险比1.5(95%CI 1.1-2.0)。
  • 剖宫产后该关联更明显,调整风险比1.8(95%CI 1.1-2.7);阴道分娩后不再显著。
  • 剖宫产后平均疼痛评分在产前抑郁症状者中显著更高。

核心结论

  • 产前抑郁症状与产后住院期间显著阿片类药物使用相关,尤其在剖宫产后。
  • 识别和治疗孕期抑郁症状是否影响产后疼痛体验和阿片类药物使用需进一步研究。

研究设计与样本

  • 回顾性队列研究,2017至2019年城市学术医疗中心,纳入在该中心接受产前保健并链接药房和账单数据与电子病历的患者。
  • 队列包括6094例分娩;2351例(38.6%)有产前爱丁堡产后抑郁量表评分。
  • 暴露为产前抑郁症状,定义为产前爱丁堡产后抑郁量表≥10;结局为显著阿片类药物使用,定义为阴道分娩后任何阿片类药物使用和剖宫产后总阿片类药物使用最高四分位数。
  • 产后阿片类药物使用通过产后第1至4天发放的阿片类药物标准转换计算吗啡毫克当量。
  • 采用泊松回归计算风险比和95%置信区间,按分娩方式分层并调整可疑混杂因素;平均产后疼痛评分为次要结局。

主要发现

  • 有产前爱丁堡产后抑郁量表评分者中11.5%最高评分≥10。
  • 10.6%的分娩观察到显著阿片类药物使用。
  • 产前抑郁症状者更可能发生显著产后阿片类药物使用,调整风险比1.5(95%置信区间1.1-2.0)。
  • 按分娩方式分层,剖宫产后关联更明显,调整风险比1.8(95%置信区间1.1-2.7);阴道分娩后不再显著。
  • 剖宫产后平均疼痛评分在产前抑郁症状产妇中显著更高。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Antepartum depression is common, and outside of childbirth preoperative anxiety and depression have been associated with heightened postoperative pain. In light of the national opioid epidemic, the relationship between antepartum depressive symptoms and postpartum opioid use is particularly relevant. OBJECTIVE: This study evaluated the association between antepartum depressive symptoms and significant postpartum opioid use during birth hospitalization. STUDY DESIGN: This retrospective cohort study at an urban academic medical center from 2017 to 2019 included patients who received prenatal care at the medical center and linked pharmacy and billing data with electronic medical records. The exposure was antepartum depressive symptoms, defined as Edinburgh Postnatal Depression Scale ≥10 during the antepartum period. The outcome was significant opioid use, defined as: (1) any opioid use following vaginal birth and (2) the top quartile of total opioid use following cesarean delivery. Postpartum opioid use was quantified using standard conversions for opioids dispensed on postpartum days 1 to 4 to calculate morphine milligram equivalents. Poisson regression was used to calculate risk ratios and 95% confidence intervals, stratified by mode of delivery and adjusted for suspected confounders. Mean postpartum pain score was a secondary outcome. RESULTS: The cohort included 6094 births; 2351 births (38.6%) had an antepartum Edinburgh Postnatal Depression Scale score. Of these, 11.5% had a maximum score ≥10. Significant opioid use was observed in 10.6% of births. We found that individuals with antepartum depressive symptoms were more likely to have significant postpartum opioid use, with an adjusted risk ratio of 1.5 (95% confidence interval, 1.1-2.0). When stratified by mode of delivery, this association was more pronounced for cesarean births, with an adjusted risk ratio of 1.8 (95% confidence interval, 1.1-2.7), and was no longer significant for vaginal births. Mean pain scores after cesarean delivery were significantly higher in parturients with antepartum depressive symptoms. CONCLUSION: Antepartum depressive symptoms were associated with significant postpartum inpatient opioid use, especially following cesarean delivery. Whether identifying and treating depressive symptoms in pregnancy may impact the pain experience and opioid use postpartum warrants further investigation.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Sudhof LS, Gompers A, Hacker MR, et al. Antepartum depressive symptoms are associated with significant postpartum opioid use. Am J Obstet Gynecol MFM. 2023. PMID: 37156465. doi:10.1016/j.ajogmf.2023.101009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。